326 related articles for article (PubMed ID: 21426159)
1. Authentic HIV-1 integrase inhibitors.
Liao C; Marchand C; Burke TR; Pommier Y; Nicklaus MC
Future Med Chem; 2010 Jul; 2(7):1107-22. PubMed ID: 21426159
[TBL] [Abstract][Full Text] [Related]
2. Advances in the development of HIV integrase strand transfer inhibitors.
Wang Y; Gu SX; He Q; Fan R
Eur J Med Chem; 2021 Dec; 225():113787. PubMed ID: 34425310
[TBL] [Abstract][Full Text] [Related]
3. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
[TBL] [Abstract][Full Text] [Related]
4. Targeting HIV-1 integrase with strand transfer inhibitors.
Li Y; Xuan S; Feng Y; Yan A
Drug Discov Today; 2015 Apr; 20(4):435-49. PubMed ID: 25486307
[TBL] [Abstract][Full Text] [Related]
5. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors.
Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8420-9. PubMed ID: 17005407
[TBL] [Abstract][Full Text] [Related]
6. Novel furocoumarins as potential HIV-1 integrase inhibitors.
Olomola TO; Mosebi S; Klein R; Traut-Johnstone T; Coates J; Hewer R; Kaye PT
Bioorg Chem; 2014 Dec; 57():1-4. PubMed ID: 25159595
[TBL] [Abstract][Full Text] [Related]
7. Computer tools in the discovery of HIV-1 integrase inhibitors.
Liao C; Nicklaus MC
Future Med Chem; 2010 Jul; 2(7):1123-40. PubMed ID: 21426160
[TBL] [Abstract][Full Text] [Related]
8. HIV type 1 integrase inhibitors: from basic research to clinical implications.
Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
[TBL] [Abstract][Full Text] [Related]
9. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors.
Xue P; Lu HH; Zhu YY; Ju XL; Pannecouque C; Zheng XJ; Liu GY; Zhang XL; Gu SX
Bioorg Med Chem Lett; 2017 Apr; 27(8):1640-1643. PubMed ID: 28314598
[TBL] [Abstract][Full Text] [Related]
11. Novel Benzoxazin-3-one Derivatives: Design, Synthesis, Molecular Modeling, Anti-HIV-1 and Integrase Inhibitory Assay.
Safakish M; Hajimahdi Z; Vahabpour R; Zabihollahi R; Zarghi A
Med Chem; 2020; 16(7):938-946. PubMed ID: 31448713
[TBL] [Abstract][Full Text] [Related]
12. Resistance to HIV-1 integrase inhibitors: A structural perspective.
Mouscadet JF; Delelis O; Marcelin AG; Tchertanov L
Drug Resist Updat; 2010; 13(4-5):139-50. PubMed ID: 20570551
[TBL] [Abstract][Full Text] [Related]
13. Heterocycle amide isosteres: An approach to overcoming resistance for HIV-1 integrase strand transfer inhibitors.
Peese KM; Naidu BN; Patel M; Li C; Langley DR; Terry B; Protack T; Gali V; Lin Z; Samanta HK; Zheng M; Jenkins S; Dicker IB; Krystal MR; Meanwell NA; Walker MA
Bioorg Med Chem Lett; 2020 Feb; 30(3):126784. PubMed ID: 31761656
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines.
Brzozowski Z; Saczewski F; Sanchez T; Kuo CL; Gdaniec M; Neamati N
Bioorg Med Chem; 2004 Jul; 12(13):3663-72. PubMed ID: 15186851
[TBL] [Abstract][Full Text] [Related]
15. In search of authentic inhibitors of HIV-1 integration.
Debyser Z; Cherepanov P; Van Maele B; De Clercq E; Witvrouw M
Antivir Chem Chemother; 2002 Jan; 13(1):1-15. PubMed ID: 12180645
[TBL] [Abstract][Full Text] [Related]
16. Caffeoyl naphthalenesulfonamide derivatives as HIV integrase inhibitors.
Xu YW; Zhao GS; Shin CG; Zang HC; Lee CK; Lee YS
Bioorg Med Chem; 2003 Aug; 11(17):3589-93. PubMed ID: 12901903
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of N-methylpyrimidone derivatives as HIV-1 integrase inhibitors.
Wang Y; Rong J; Zhang B; Hu L; Wang X; Zeng C
Bioorg Med Chem; 2015 Feb; 23(4):735-41. PubMed ID: 25618597
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells.
Hazuda DJ; Felock P; Witmer M; Wolfe A; Stillmock K; Grobler JA; Espeseth A; Gabryelski L; Schleif W; Blau C; Miller MD
Science; 2000 Jan; 287(5453):646-50. PubMed ID: 10649997
[TBL] [Abstract][Full Text] [Related]
19. Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors.
Rajamaki S; Innitzer A; Falciani C; Tintori C; Christ F; Witvrouw M; Debyser Z; Massa S; Botta M
Bioorg Med Chem Lett; 2009 Jul; 19(13):3615-8. PubMed ID: 19447621
[TBL] [Abstract][Full Text] [Related]
20. Design of novel bioisosteres of beta-diketo acid inhibitors of HIV-1 integrase.
Sechi M; Sannia L; Carta F; Palomba M; Dallocchio R; Dessì A; Derudas M; Zawahir Z; Neamati N
Antivir Chem Chemother; 2005; 16(1):41-61. PubMed ID: 15739621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
